This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by BROADUS, A. E. Articles by ELLISON, A. F. Search for Related Content PubMed PubMed Citation Articles by BROADUS, A. E. Articles by ELLISON, A. F.

A Consideration of the Hormonal Basis and Phosphate Leak Hypothesis of Absorptive Hypercalciuria^*

Department of Internal Medicine, Yale University New Haven, Connecticut 06510 Research and Medical Services, Veterans Administration Medical Center Houston, Texas 77211

Address requests for reprints to: Arthur E. Broadus, M.D., Ph.D., Department of Internal Medicine, Yale UniversitySchool of Medicine, Box 3333, 2088 LMP, New Haven, Connecticut 06510.

Fifty patients with absorptive hypercalciuria (AH), 25 normal subjects (NS),and 25 nonhypercalciuric patients with stone disease (NHSF) were studied using an oral calcium tolerance test and 24–h urine collections on both a restricted and an unrestricted calcium intake.

Mean (±SD) fasting fractional calcium excretion was increased in the patients with AH (2.7 ±1.1% us. 1.4 ± 0.6% in the NS; P < 0.001) and was negatively correlated with fasting nephrogenous cAMP, suggesting that this renal calcium leak was secondary to parathyroid suppression.

Plasma 1,25-dihydroxyvitamin D [1,25-(OH)₂D] was elevated in 80% of patients with AH and was high normal in the remaining 20%. Ten patients, selected on the basis of results for 1,25- (0H)₂D greater than 4 SD from the normal mean, displayed a particularly severe pattern of abnormalities, including mild hypercalcemia in two patients.

Pooled data from the NS and patients with AH revealed a significant negative correlation between the plasma concentration of 1,25-(OH)₂D and the renal phosphate threshold (r = –0.40; P < 0.001), but this correlation lost significance when the NHSF were substituted for the NS as a control group (r = –0.07; P = NS).

These findings 1) provide a pathophysiological basis for the increase in fasting calcium excretion commonly observed in hypercalciuric patients, and 2) stress the importance of circulating 1,25-(OH)₂D in the pathogenesis of the syndrome, but 3) fail to support the phosphate leak theory of pathogenesis.

^* This work was supported in part by NIH grants RR-125 and AM 20570, the General Clinical Research Center, Yale-New Haven, Hospital, and the V.A.

Received July 2, 1983.